Bé Wieringa - Publications

Affiliations: 
Cell Biology Radboud University Nijmegen, Nijmegen, Gelderland, Netherlands 
Area:
Energy & Redox Metabolism
Website:
http://ncmls.nl/people/wieringa/

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 André LM, van Cruchten RTP, Willemse M, Bezstarosti K, Demmers JAA, van Agtmaal EL, Wansink DG, Wieringa B. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG) Repeat. International Journal of Molecular Sciences. 20. PMID 31766224 DOI: 10.3390/ijms20225685  0.357
2019 van Cruchten RTP, Wieringa B, Wansink DG. Expanded CUG repeats in transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences. Rna (New York, N.Y.). 25: 481-495. PMID 30700578 DOI: 10.1261/rna.068940.118  0.31
2018 André LM, Ausems CRM, Wansink DG, Wieringa B. Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy. Frontiers in Neurology. 9: 368. PMID 29892259 DOI: 10.3389/fneur.2018.00368  0.305
2017 Gudde AEEG, van Kessel IDG, André LM, Wieringa B, Wansink DG. Trinucleotide-repeat expanded and normal DMPK transcripts contain unusually long poly(A) tails despite differential nuclear residence. Biochimica Et Biophysica Acta. PMID 28435090 DOI: 10.1016/j.bbagrm.2017.04.002  0.305
2017 van Agtmaal EL, André LM, Willemse M, Cumming SA, van Kessel ID, van den Broek WJ, Gourdon G, Furling D, Mouly V, Monckton DG, Wansink DG, Wieringa B. CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing. Molecular Therapy : the Journal of the American Society of Gene Therapy. 25: 24-43. PMID 28129118 DOI: 10.1016/j.ymthe.2016.10.014  0.36
2017 Gudde AE, van Heeringen SJ, de Oude AI, van Kessel ID, Estabrook J, Wang ET, Wieringa B, Wansink DG. Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat. Rna Biology. 0. PMID 28102759 DOI: 10.1080/15476286.2017.1279787  0.3
2016 Gudde AE, González-Barriga A, van den Broek WJ, Wieringa B, Wansink DG. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle. Human Molecular Genetics. PMID 26908607 DOI: 10.1093/hmg/ddw042  0.339
2015 González-Barriga A, Kranzen J, Croes HJ, Bijl S, van den Broek WJ, van Kessel ID, van Engelen BG, van Deutekom JC, Wieringa B, Mulders SA, Wansink DG. Cell membrane integrity in myotonic dystrophy type 1: implications for therapy. Plos One. 10: e0121556. PMID 25799359 DOI: 10.1371/journal.pone.0121556  0.313
2014 González-Barriga A, Kranzen J, Croes HJE, Broek WJAvd, Engelen BGMv, Deutekom JCTv, Wieringa B, Mulders SAM, Wansink DG. G.P.131: Cell membrane integrity in myotonic dystrophy type 1: Implications for therapy Neuromuscular Disorders. 24: 840. DOI: 10.1016/J.Nmd.2014.06.161  0.32
2013 González-Barriga A, Mulders SA, van de Giessen J, Hooijer JD, Bijl S, van Kessel ID, van Beers J, van Deutekom JC, Fransen JA, Wieringa B, Wansink DG. Design and analysis of effects of triplet repeat oligonucleotides in cell models for myotonic dystrophy. Molecular Therapy. Nucleic Acids. 2: e81. PMID 23511335 DOI: 10.1038/mtna.2013.9  0.32
2013 Nabuurs CI, Choe CU, Veltien A, Kan HE, van Loon LJ, Rodenburg RJ, Matschke J, Wieringa B, Kemp GJ, Isbrandt D, Heerschap A. Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake. The Journal of Physiology. 591: 571-92. PMID 23129796 DOI: 10.1113/Jphysiol.2012.241760  0.303
2012 Valsecchi F, Monge C, Forkink M, de Groof AJ, Benard G, Rossignol R, Swarts HG, van Emst-de Vries SE, Rodenburg RJ, Calvaruso MA, Nijtmans LG, Heeman B, Roestenberg P, Wieringa B, Smeitink JA, et al. Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts. Biochimica Et Biophysica Acta. 1817: 1925-36. PMID 22430089 DOI: 10.1016/J.Bbabio.2012.03.006  0.334
2012 Gerrits L, Overheul GJ, Derks RC, Wieringa B, Hendriks WJ, Wansink DG. Gene duplication and conversion events shaped three homologous, differentially expressed myosin regulatory light chain (MLC2) genes. European Journal of Cell Biology. 91: 629-39. PMID 22425609 DOI: 10.1016/j.ejcb.2012.02.001  0.353
2011 Mulders SA, van Horssen R, Gerrits L, Bennink MB, Pluk H, de Boer-van Huizen RT, Croes HJ, Wijers M, van de Loo FA, Fransen J, Wieringa B, Wansink DG. Abnormal actomyosin assembly in proliferating and differentiating myoblasts upon expression of a cytosolic DMPK isoform. Biochimica Et Biophysica Acta. 1813: 867-77. PMID 21295081 DOI: 10.1016/j.bbamcr.2011.01.024  0.351
2009 Oude Ophuis RJ, Wijers M, Bennink MB, van de Loo FA, Fransen JA, Wieringa B, Wansink DG. A tail-anchored myotonic dystrophy protein kinase isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis. Plos One. 4: e8024. PMID 19946639 DOI: 10.1371/journal.pone.0008024  0.35
2009 Mulders SA, van den Broek WJ, Wheeler TM, Croes HJ, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 106: 13915-20. PMID 19667189 DOI: 10.1073/pnas.0905780106  0.314
2009 Oude Ophuis RJ, Mulders SA, van Herpen RE, van de Vorstenbosch R, Wieringa B, Wansink DG. DMPK protein isoforms are differentially expressed in myogenic and neural cell lineages. Muscle & Nerve. 40: 545-55. PMID 19626675 DOI: 10.1002/mus.21352  0.352
2009 Streijger F, Pluk H, Oerlemans F, Beckers G, Bianco AC, Ribeiro MO, Wieringa B, Van der Zee CE. Mice lacking brain-type creatine kinase activity show defective thermoregulation. Physiology & Behavior. 97: 76-86. PMID 19419668 DOI: 10.1016/j.physbeh.2009.02.003  0.305
2009 Kan HE, Veltien A, Arnts H, Nabuurs CI, Luijten B, de Haan A, Wieringa B, Heerschap A. Gated dynamic 31P MRS shows reduced contractile phosphocreatine breakdown in mice deficient in cytosolic creatine kinase and adenylate kinase. Nmr in Biomedicine. 22: 523-31. PMID 19156695 DOI: 10.1002/Nbm.1364  0.32
2007 Renema WK, Kan HE, Wieringa B, Heerschap A. In vivo magnetic resonance spectroscopy of transgenic mouse models with altered high-energy phosphoryl transfer metabolism. Nmr in Biomedicine. 20: 448-67. PMID 17274105 DOI: 10.1002/Nbm.1117  0.314
2006 van Herpen RE, Tjeertes JV, Mulders SA, Oude Ophuis RJ, Wieringa B, Wansink DG. Coiled-coil interactions modulate multimerization, mitochondrial binding and kinase activity of myotonic dystrophy protein kinase splice isoforms. The Febs Journal. 273: 1124-36. PMID 16519679 DOI: 10.1111/j.1742-4658.2006.05138.x  0.309
2005 van Herpen RE, Oude Ophuis RJ, Wijers M, Bennink MB, van de Loo FA, Fransen J, Wieringa B, Wansink DG. Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors. Molecular and Cellular Biology. 25: 1402-14. PMID 15684391 DOI: 10.1128/MCB.25.4.1402-1414.2005  0.348
2004 O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Human Molecular Genetics. 13: 2505-18. PMID 15317754 DOI: 10.1093/Hmg/Ddh266  0.372
2004 Janssen E, Kuiper J, Hodgson D, Zingman LV, Alekseev AE, Terzic A, Wieringa B. Two structurally distinct and spatially compartmentalized adenylate kinases are expressed from the AK1 gene in mouse brain. Molecular and Cellular Biochemistry. 256: 59-72. PMID 14977170 DOI: 10.1023/B:Mcbi.0000009859.15267.Db  0.342
2004 Dzeja PP, Terzic A, Wieringa B. Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice. Molecular and Cellular Biochemistry. 256: 13-27. PMID 14977167 DOI: 10.1023/B:Mcbi.0000009856.23646.38  0.315
2003 Wansink DG, van Herpen RE, Coerwinkel-Driessen MM, Groenen PJ, Hemmings BA, Wieringa B. Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization. Molecular and Cellular Biology. 23: 5489-501. PMID 12897125 DOI: 10.1128/MCB.23.16.5489-5501.2003  0.349
2003 Janssen E, Terzic A, Wieringa B, Dzeja PP. Impaired intracellular energetic communication in muscles from creatine kinase and adenylate kinase (M-CK/AK1) double knock-out mice. The Journal of Biological Chemistry. 278: 30441-9. PMID 12730234 DOI: 10.1074/Jbc.M303150200  0.317
2003 Westerlaken JH, Van der Zee CE, Peters W, Wieringa B. The DMWD protein from the myotonic dystrophy (DM1) gene region is developmentally regulated and is present most prominently in synapse-dense brain areas. Brain Research. 971: 116-27. PMID 12691844 DOI: 10.1016/S0006-8993(03)02430-2  0.336
2003 Janssen E, de Groof A, Wijers M, Fransen J, Dzeja PP, Terzic A, Wieringa B. Adenylate kinase 1 deficiency induces molecular and structural adaptations to support muscle energy metabolism. The Journal of Biological Chemistry. 278: 12937-45. PMID 12562761 DOI: 10.1074/jbc.M211465200  0.343
2002 Makarchikov AF, Wins P, Janssen E, Wieringa B, Grisar T, Bettendorff L. Adenylate kinase 1 knockout mice have normal thiamine triphosphate levels. Biochimica Et Biophysica Acta. 1592: 117-21. PMID 12379473 DOI: 10.1016/S0167-4889(02)00277-X  0.318
2002 van den Broek WJ, Nelen MR, Wansink DG, Coerwinkel MM, te Riele H, Groenen PJ, Wieringa B. Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Human Molecular Genetics. 11: 191-8. PMID 11809728 DOI: 10.1093/Hmg/11.2.191  0.363
2001 de Groof AJ, Smeets B, Groot Koerkamp MJ, Mul AN, Janssen EE, Tabak HF, Wieringa B. Changes in mRNA expression profile underlie phenotypic adaptations in creatine kinase-deficient muscles. Febs Letters. 506: 73-8. PMID 11591374 DOI: 10.1016/S0014-5793(01)02879-4  0.323
2001 de Groof AJ, Oerlemans FT, Jost CR, Wieringa B. Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles. Muscle & Nerve. 24: 1188-96. PMID 11494272 DOI: 10.1002/mus.1131  0.312
2000 Janssen E, Dzeja PP, Oerlemans F, Simonetti AW, Heerschap A, de Haan A, Rush PS, Terjung RR, Wieringa B, Terzic A. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. The Embo Journal. 19: 6371-81. PMID 11101510 DOI: 10.1093/Emboj/19.23.6371  0.317
2000 Pucar D, Janssen E, Dzeja PP, Juranic N, Macura S, Wieringa B, Terzic A. Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. The Journal of Biological Chemistry. 275: 41424-9. PMID 11006295 DOI: 10.1074/jbc.M007903200  0.308
2000 Groenen PJTA, Wansink DG, Coerwinkel M, Van Den Broek W, Jansen G, Wieringa B. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties Human Molecular Genetics. 9: 605-616. PMID 10699184 DOI: 10.1093/Hmg/9.4.605  0.393
1999 Van Den Maagdenberg AMJM, Bachner D, Schepens JTG, Peters W, Fransen JAM, Wieringa B, Hendriks WJAJ. The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP-SL and PTPBR7, that display distinct patterns of expression during neural development European Journal of Neuroscience. 11: 3832-3844. PMID 10583472 DOI: 10.1046/j.1460-9568.1999.00802.x  0.371
1999 ten Dam GB, Wieringa B, Poels LG. Alternative splicing of CD45 pre-mRNA is uniquely obedient to conditions in lymphoid cells. Biochimica Et Biophysica Acta. 1446: 317-33. PMID 10524206 DOI: 10.1016/S0167-4781(99)00119-0  0.315
1998 Groenen P, Wieringa B. Expanding complexity in myotonic dystrophy Bioessays. 20: 901-912. PMID 9872056 DOI: 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0  0.404
1998 Steeghs K, Oerlemans F, De Haan A, Heerschap A, Verdoodt L, De Bie M, Ruitenbeek W, Benders A, Jost C, Van Deursen J, Tullson P, Terjung R, Jap P, Jacob W, Pette D, ... Wieringa B, et al. Cytoarchitectural and metabolic adaptations in muscles with mitochondrial and cytosolic creatine kinase deficiencies Molecular and Cellular Biochemistry. 184: 183-194. PMID 9746321 DOI: 10.1007/978-1-4615-5653-4_14  0.326
1998 Boehm E, Veksler V, Mateo P, Lenoble C, Wieringa B, Ventura-Clapier R. Maintained coupling of oxidative phosphorylation to creatine kinase activity in sarcomeric mitochondrial creatine kinase-deficient mice Journal of Molecular and Cellular Cardiology. 30: 901-912. PMID 9618231 DOI: 10.1006/jmcc.1998.0692  0.301
1998 Tullson PC, Rush JWE, Wieringa B, Terjung RL. Alterations in AMP deaminase activity and kinetics in skeletal muscle of creatine kinase-deficient mice American Journal of Physiology - Cell Physiology. 274: C1411-C1416. PMID 9612229 DOI: 10.1152/Ajpcell.1998.274.5.C1411  0.33
1998 De Bruin WCC, Te Morsche RHM, Wagenmans MJM, Alferink JC, Townsend AJ, Wieringa B, Peters WHM. Identification of a novel murine glutathione S-transferase class mu gene Biochemical Journal. 330: 623-626. PMID 9480867 DOI: 10.1042/Bj3300623  0.363
1997 Schaapveld RQ, Schepens JT, Robinson GW, Attema J, Oerlemans FT, Fransen JA, Streuli M, Wieringa B, Hennighausen L, Hendriks WJ. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Developmental Biology. 188: 134-46. PMID 9245518 DOI: 10.1006/dbio.1997.8630  0.335
1997 van den Hurk JA, Hendriks W, van de Pol DJ, Oerlemans F, Jaissle G, Rüther K, Kohler K, Hartmann J, Zrenner E, van Bokhoven H, Wieringa B, Ropers HH, Cremers FP. Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Human Molecular Genetics. 6: 851-8. PMID 9175730 DOI: 10.1093/Hmg/6.6.851  0.644
1997 Steeghs K, Benders A, Oerlemans F, De Haan A, Heerschap A, Ruitenbeek W, Jost C, Van Deursen J, Perryman B, Pette D, Brückwilder M, Koudijs J, Paul J, Veerkamp J, Wieringa B. Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies Cell. 89: 93-103. PMID 9094718 DOI: 10.1016/S0092-8674(00)80186-5  0.316
1996 Van Den Maagdenberg AMJM, Olde Weghuis D, Rijss J, Merkx GF, Wieringa B, Geurts Van Kessel A, Hendriks WJAJ. The gene (PTPN13) encoding the protein tyrosine phosphatase PTP-BL/PTP-BAS is located in mouse chromosome region 5E/F and human chromosome region 4q21 Cytogenetics and Cell Genetics. 74: 153-155. PMID 8893825 DOI: 10.1159/000134405  0.383
1996 Berger W, van de Pol D, Bächner D, Oerlemans F, Winkens H, Hameister H, Wieringa B, Hendriks W, Ropers HH. An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. Human Molecular Genetics. 5: 51-9. PMID 8789439 DOI: 10.1093/hmg/5.1.51  0.542
1996 Jansen G, Groenen PJ, Bächner D, Jap PH, Coerwinkel M, Oerlemans F, van den Broek W, Gohlsch B, Pette D, Plomp JJ, Molenaar PC, Nederhoff MG, van Echteld CJ, Dekker M, Berns A, ... ... Wieringa B, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genetics. 13: 316-24. PMID 8673131 DOI: 10.1038/ng0796-316  0.363
1996 Van Den Maagdenberg AMJM, Weghuis DO, Rijss J, Van De Wetering RAC, Wieringa B, Van Geurts Kessel A, Hendriks WJAJ. Assignment of the human gene for receptor-type protein tyrosine phosphatase IA-2 (PTPRN) to chromosome region 2q35→q36.1 and identification of an intragenic genetic marker Cytogenetics and Cell Genetics. 73: 145-148. PMID 8646884 DOI: 10.1159/000134327  0.422
1996 Hendriks W, Brugman C, Richter KH, Van Hooijdonk C, Schepens J, Schalkwijk J, Wieringa B. Protein-tyrosine phosphatases expressed in mouse epidermal keratinocytes Journal of Investigative Dermatology. 106: 972-976. PMID 8618060 DOI: 10.1111/1523-1747.Ep12338472  0.329
1995 Hendriks W, Schepens J, Bachner D, Rijss J, Zeeuwen P, Zechner U, Hameister H, Wieringa B. Molecular cloning of a mouse epithelial protein-tyrosine phosphatase with similarities to submembranous proteins Journal of Cellular Biochemistry. 59: 418-430. PMID 8749712 DOI: 10.1002/jcb.240590403  0.341
1995 Van den Maagdenberg AMJM, Van den Hurk HH, Weghuis DO, Wieringa B, Van Kessel AG, Hendriks WJAJ. Assignment of the human protein tyrosine phosphatase epsilon (PTPRE) gene to chromosome 10q26 by fluorescence in situ hybridization Genomics. 30: 128-129. PMID 8595895 DOI: 10.1006/geno.1995.0026  0.377
1995 De Bruijn DRH, Oerlemans F, Hendriks W, Baats E, Ploemacher R, Wieringa B, Van Kessel AG. Normal development, growth and reproduction in cellular retinoic acid binding protein-I (CRABPI) null mutant mice Differentiation. 58: 141-148. PMID 7890139 DOI: 10.1046/j.1432-0436.1995.5820141.x  0.327
1995 Hendriks W, Schepens J, Brugman C, Zeeuwen P, Wieringa B. A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain Biochemical Journal. 305: 499-504. PMID 7832766 DOI: 10.1042/Bj3050499  0.335
1995 Schaapveld RQJ, Van den Maagdenberg AMJM, Schepens JTG, Weghuis DO, Van Kessel AG, Wieringa B, Hendriks WJAJ. The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: Cloning, characterization, and chromosomal localization Genomics. 27: 124-130. PMID 7665159 DOI: 10.1006/geno.1995.1014  0.422
1995 Jansen G, Bachner D, Coerwinkel M, Wormskamp N, Hameister H, Wieringa B. Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus Human Molecular Genetics. 4: 843-852. PMID 7633444 DOI: 10.1093/Hmg/4.5.843  0.406
1995 Steeghs K, Oerlemans F, Wieringa B. Mice deficient in ubiquitous mitochondrial creatine kinase are viable and fertile Bba - Bioenergetics. 1230: 130-138. PMID 7619831 DOI: 10.1016/0005-2728(95)00044-J  0.333
1995 Steeghs K, Peters W, Bruckwilder M, Croes H, Van Alewijk D, Wieringa B. Mouse ubiquitous mitochondrial creatine kinase: Gene organization and consequences from inactivation in mouse embryonic stem cells Dna and Cell Biology. 14: 539-553. PMID 7598809 DOI: 10.1089/Dna.1995.14.539  0.397
1995 Van Ree JH, Van Den Broek WJJA, Van Der Zee A, Dahlmans VEH, Wieringa B, Frants RR, Havekes LM, Hofker MH. Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: Effects on mRNA expression levels of gene cluster members Human Molecular Genetics. 4: 1403-1409. PMID 7581381 DOI: 10.1093/Hmg/4.8.1403  0.373
1994 Hendriks W, Brugman C, Schepens J, Wieringa B. Rapid assessment of protein-tyrosine phosphatase expression levels by RT-PCR with degenerate primers Molecular Biology Reports. 19: 105-108. PMID 8072490 DOI: 10.1007/BF00997155  0.335
1994 Iles DE, Lehmann-Horn F, Scherer SW, Tsui LC, Olde Weghuis D, Suljkerbuijk RF, Heytens L, Mikala G, Schwartz A, Ellis FR, Stewart AD, Deufel T, Wieringa B. Localization of the gene encoding the α2/δ-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families Human Molecular Genetics. 3: 969-975. PMID 7951247 DOI: 10.1093/Hmg/3.6.969  0.392
1994 Steeghs K, Merkx G, Wieringa B. The ubiquitous mitochondrial creatine kinase gene maps to a conserved region on human chromosome 15q15 and mouse chromosome 2 bands F1-F3 Genomics. 24: 193-195. PMID 7896282 DOI: 10.1006/geno.1994.1604  0.356
1993 Jansen G, Coerwinkel-Driessen M, Nillesen W, Brunner H, Wieringa B. Dinucleotide repeat polymorphism at locus D19S207, close to the myotonic dystrophy (DM) gene Human Molecular Genetics. 2: 333. PMID 8499928 DOI: 10.1093/Hmg/2.3.333  0.525
1993 Mahadevan MS, Amemiya C, Jansen G, Sabourin L, Baird S, Neville CE, Wormskamp N, Segers B, Batzer M, Lamerdin J, De Jong P, Wieringa B, Korneluk RG. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene Human Molecular Genetics. 2: 299-304. PMID 8499920 DOI: 10.1093/Hmg/2.3.299  0.392
1993 Brunner HG, Jansen G, Nillesen W, Nelen MR, de Die CE, Höweler CJ, van Oost BA, Wieringa B, Ropers HH, Smeets HJ. Brief report: reverse mutation in myotonic dystrophy. The New England Journal of Medicine. 328: 476-80. PMID 8421477 DOI: 10.1056/NEJM199302183280705  0.514
1993 Jansen G, Bartolomei M, Kalscheuer V, Merkx G, Wormskamp N, Mariman E, Smeets D, Ropers HH, Wieringa B. No imprinting involved in the expression of DM-kinase mRNAs in mouse and human tissues Human Molecular Genetics. 2: 1221-1227. PMID 8401505 DOI: 10.1093/HMG/2.8.1221  0.519
1993 van Deursen J, Heerschap A, Oerlemans F, Rultenbeek W, Jap P, ter Laak H, Wieringa B. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity Cell. 74: 621-631. PMID 8358791 DOI: 10.1016/0092-8674(93)90510-W  0.315
1993 Brunner HG, Höweler CJ, Smeets HJ, Wieringa B. [An unstable mutation as cause of myotonic dystrophy]. Nederlands Tijdschrift Voor Geneeskunde. 137: 2468-72. PMID 8272119  0.353
1993 Brunner HG, Brüggenwirth HT, Nillesen W, Jansen G, Hamel BC, Hoppe RL, de Die CE, Höweler CJ, van Oost BA, Wieringa B. Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). American Journal of Human Genetics. 53: 1016-23. PMID 8213829  0.391
1992 Deursen Jv, Schepens J, Peters W, Meijer D, Grosveld G, Hendriks W, Wieringa B. Genetic variability of the murine creatine kinase B gene locus and related pseudogenes in different inbred strains of mice. Genomics. 12: 340-349. PMID 1740343 DOI: 10.1016/0888-7543(92)90383-4  0.393
1992 Jansen G, de Jong PJ, Amemiya C, Aslanidis C, Shaw DJ, Harley HG, Brook JD, Fenwick R, Korneluk RG, Tsilfidis C, Shutler G, Hermens R, Wormskamp NGM, Smeets HJM, Wieringa B. Physical and genetic characterization of the distal segment of the myotonic dystrophy area on 19q Genomics. 13: 509-517. PMID 1639379 DOI: 10.1016/0888-7543(92)90118-C  0.419
1992 Schepens J, Zeeuwen P, Wieringa B, Hendriks W. Identification and typing of members of the protein-tyrosine phosphatase gene family expressed in mouse brain Molecular Biology Reports. 16: 241-248. PMID 1454056 DOI: 10.1007/BF00419663  0.353
1992 Brunner HG, Nillesen W, van Oost BA, Jansen G, Wieringa B, Ropers HH, Smeets HJ. Presymptomatic diagnosis of myotonic dystrophy. Journal of Medical Genetics. 29: 780-4. PMID 1453426  0.608
1992 Smeets HJ, Nillesen WM, Los F, Busch HF, Korneluk RG, Wieringa B, Brunner HG. Prenatal diagnosis of myotonic dystrophy by direct mutation analysis. Lancet (London, England). 340: 237-8. PMID 1353153 DOI: 10.1016/0140-6736(92)90500-3  0.433
1991 Van Deursen J, Lovell-Badge R, Oerlemans F, Schepens J, Wieringa B. Modulation of gene activity by consecutive gene targeting of one creatine kinase M allele in mouse embryonic stem cells Nucleic Acids Research. 19: 2637-2643. PMID 2041741 DOI: 10.1093/Nar/19.10.2637  0.397
1991 Brook JD, Knight SJL, Roberts SH, Harley HG, Walsh KV, Rundle SA, Freyne K, Koch MC, Epstein ND, Wieringa B, Schonk D, Smeets H, Haddingham K, Siciliano MJ, Palmer DK, et al. The physical map of chromosome arm 19q: some new assignments, confirmations and re-assessments Human Genetics. 87: 65-72. PMID 2037284 DOI: 10.1007/BF01213095  0.356
1991 Brunner HG, Spaans F, Smeets HJ, Coerwinkel-Driessen M, Hulsebos T, Wieringa B, Ropers HH. Genetic linkage with chromosome 19 but not chromosome 17 in a family with myotonic dystrophy associated with hereditary motor and sensory neuropathy. Neurology. 41: 80-4. PMID 1985299 DOI: 10.1212/Wnl.41.1.80  0.597
1991 Brunner HG, Smeets HJ, Nillesen W, van Oost BA, van den Biezenbos JB, Joosten EM, Pinckers AJ, Hamel BC, Theeuwes AG, Wieringa B. Myotonic dystrophy. Predictive value of normal results on clinical examination. Brain : a Journal of Neurology. 114: 2303-11. PMID 1933246 DOI: 10.1093/Brain/114.5.2303  0.521
1991 Smeets HJ, Hermens R, Brunner HG, Ropers HH, Wieringa B. Identification of variable simple sequence motifs in 19q13.2-qter: markers for the myotonic dystrophy locus. Genomics. 9: 257-63. PMID 1840564 DOI: 10.1016/0888-7543(91)90250-I  0.657
1991 Mariman E, Wieringa B. Expression of the gene encoding human brain creatine kinase depends on sequences immediately following the transcription start point. Gene. 102: 205-212. PMID 1840537 DOI: 10.1016/0378-1119(91)90079-Q  0.373
1990 Diergaarde PJ, Wieringa B, Bleeker-Wagemakers EM, Sims KB, Breakefield XO, Ropers HH. Physical fine-mapping of a deletion spanning the Norrie gene. Human Genetics. 84: 22-6. PMID 2606473 DOI: 10.1007/BF00210665  0.402
1990 Cremers FP, Sankila EM, Brunsmann F, Jay M, Jay B, Wright A, Pinckers AJ, Schwartz M, van de Pol DJ, Wieringa B. Deletions in patients with classical choroideremia vary in size from 45 kb to several megabases. American Journal of Human Genetics. 47: 622-8. PMID 2220804  0.535
1990 Cremers FP, van de Pol DJ, van Kerkhoff LP, Wieringa B, Ropers HH. Cloning of a gene that is rearranged in patients with choroideraemia. Nature. 347: 674-7. PMID 2215697 DOI: 10.1038/347674A0  0.641
1990 Cremers FP, Brunsmann F, Berger W, van Kerkhoff EP, van de Pol TJ, Wieringa B, Pawlowitzki IH, Ropers HH. Cloning of the breakpoints of a deletion associated with choroidermia. Human Genetics. 86: 61-4. PMID 1979308 DOI: 10.1007/Bf00205174  0.65
1990 van de Pol TJ, Cremers FP, Brohet RM, Wieringa B, Ropers HH. Derivation of clones from the choroideremia locus by preparative field inversion gel electrophoresis. Nucleic Acids Research. 18: 725-31. PMID 1969148 DOI: 10.1093/NAR/18.4.725  0.633
1989 Cremers FP, van de Pol DJ, Diergaarde PJ, Wieringa B, Nussbaum RL, Schwartz M, Ropers HH. Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics. 4: 41-6. PMID 2914708 DOI: 10.1016/0888-7543(89)90312-1  0.66
1989 Cremers FP, van de Pol DJ, Wieringa B, Collins FS, Sankila EM, Siu VM, Flintoff WF, Brunsmann F, Blonden LA, Ropers HH. Chromosomal jumping from the DXS165 locus allows molecular characterization of four microdeletions and a de novo chromosome X/13 translocation associated with choroideremia. Proceedings of the National Academy of Sciences of the United States of America. 86: 7510-4. PMID 2798422 DOI: 10.1073/Pnas.86.19.7510  0.642
1989 Mariman ECM, Schepens JTG, Wieringa B. Complete nucleotide sequence of the human creatine kinase B gene. Nucleic Acids Research. 17: 6385-6385. PMID 2771648 DOI: 10.1093/Nar/17.15.6385  0.343
1989 Brunner HG, Korneluk RG, Coerwinkel-Driessen M, MacKenzie A, Smeets H, Lambermon HM, van Oost BA, Wieringa B, Ropers HH. Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM). Human Genetics. 81: 308-10. PMID 2703233 DOI: 10.1007/Bf00283680  0.607
1989 Niemann SC, Schonk D, van Dijk P, Wieringa B, Grzeschik KH, Bartels I. Regional localization of the gene encoding pregnancy specific beta-1-glycoprotein 1 (PSBG1) to human chromosome 19q13.1. Cytogenetics and Cell Genetics. 52: 95-7. PMID 2612223 DOI: 10.1159/000132851  0.351
1989 Steeg Hv, Oostrom CTMv, Martens JWM, Kreyl CFv, Schepens J, Wieringa B. Nucleotide sequence of the human ornithine decarboxylase gene. Nucleic Acids Research. 17: 8855-8856. PMID 2587220 DOI: 10.1093/Nar/17.21.8855  0.329
1989 Brunner HG, Smeets H, Lambermon HM, Coerwinkel-Driessen M, van Oost BA, Wieringa B, Ropers HH. A multipoint linkage map around the locus for myotonic dystrophy on chromosome 19. Genomics. 5: 589-95. PMID 2575588 DOI: 10.1016/0888-7543(89)90027-X  0.612
1989 Smeets HJ, Brunner HG, Ropers HH, Wieringa B. Use of variable simple sequence motifs as genetic markers: application to study of myotonic dystrophy. Human Genetics. 83: 245-51. PMID 2571562 DOI: 10.1007/Bf00285165  0.638
1988 Smeets B, Poddighe J, Brunner H, Ropers H, Wieringa B. Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides. Human Genetics. 80: 49-52. PMID 3417303 DOI: 10.1007/Bf00451455  0.619
1988 Cremers FP, van de Pol TJ, Wieringa B, Hofker MH, Pearson PL, Pfeiffer RA, Mikkelsen M, Tabor A, Ropers HH. Molecular analysis of male-viable deletions and duplications allows ordering of 52 DNA probes on proximal Xq. American Journal of Human Genetics. 43: 452-61. PMID 3177387  0.561
1988 Brunner HG, van Bennekom A, Lambermon EM, Oei TL, Cremers WR, Wieringa B, Ropers HH. The gene for X-linked progressive mixed deafness with perilymphatic gusher during stapes surgery (DFN3) is linked to PGK. Human Genetics. 80: 337-40. PMID 2904400  0.602
1988 Coerwinkel-Driessen M, Schepens J, Zandvoort Pv, Oost Bv, Mariman E, Wieringa B. NcoI RFLP at the creatine kinase-muscle type gene locus (CKMM, chromosome 19). Nucleic Acids Research. 16: 8743-8743. PMID 2901730 DOI: 10.1093/Nar/16.17.8743  0.428
1988 Hulsebos T, Schonk D, van Dalen I, Coerwinkel-Driessen M, Schepens J, Ropers HH, Wieringa B. Isolation and characterization of alphoid DNA sequences specific for the pericentric regions of chromosomes 4, 5, 9, and 19. Cytogenetics and Cell Genetics. 47: 144-8. PMID 2837365 DOI: 10.1159/000132533  0.54
1987 Hulsebos T, Wieringa B, Hochstenbach R, Smeets D, Schepens J, Oerlemans F, Zimmer J, Ropers HH. Toward early diagnosis of myotonic dystrophy: construction and characterization of a somatic cell hybrid with a single human der(19) chromosome. Cytogenetics and Cell Genetics. 43: 47-56. PMID 3502690 DOI: 10.1159/000132297  0.542
1987 Cremers FP, Brunsmann F, van de Pol TJ, Pawlowitzki IH, Paulsen K, Wieringa B, Ropers HH. Deletion of the DXS165 locus in patients with classical choroideremia. Clinical Genetics. 32: 421-3. PMID 3481306  0.531
1987 Davis MB, Schonk D, Monteiro M, Oerlemans F, Povey S, Wieringa B. Localization of PEPD to the long arm of chromosome 19. Annals of Human Genetics. 51: 195-9. PMID 3479944 DOI: 10.1111/J.1469-1809.1987.Tb00871.X  0.329
1987 Cremers FP, Pfeiffer RA, van de Pol TJ, Hofker MH, Kruse TA, Wieringa B, Ropers HH. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Human Genetics. 77: 23-7. PMID 3476455 DOI: 10.1007/Bf00284707  0.629
1987 Kranen HJv, Zande Lvd, Kreijl CFv, Bisschop A, Wieringa B. Cloning and nucleotide sequence of rat ornithine decarboxylase cDNA. Gene. 60: 145-155. PMID 3443298 DOI: 10.1016/0378-1119(87)90222-8  0.303
1987 Smeets H, Markslag P, Bril J, Hulsebos T, Brunner H, Schonk D, Ropers HH, Wieringa B. EcoRI RFLP at 19 cen-q13.2 identified by the anonymous DNA sequence pPM6.7 (D19S18). Nucleic Acids Research. 15: 8120. PMID 2890138 DOI: 10.1093/Nar/15.19.8120  0.606
1987 Mariman ECM, Schepens J, Kessel AGv, Wieringa B. EcoRI RFLP at the creatine kinase-brain type gene locus (CKBB, chromosome 14). Nucleic Acids Research. 15: 5502-5502. PMID 2885812 DOI: 10.1093/Nar/15.13.5502  0.38
1987 Schepens J, Hulsebos T, Smeets H, Coerwinkel M, Brunner H, Ropers HH, Wieringa B. A locus at 19cen-19q13.2 (D19S15) containing three RFLPs linked to myotonic dystrophy (DM) is recognized by probe pJSB6. Nucleic Acids Research. 15: 3193. PMID 2882485 DOI: 10.1093/Nar/15.7.3193  0.616
1987 Schepens J, Smeets H, Hulsebos T, Brunner H, Wieringa B. Isolation of a polymorphic DNA sequence pJSB11 (D19S16) from the human chromosome 19cen-q13.2 region linked to the myotonic dystrophy (DM) gene. Nucleic Acids Research. 15: 3192-3192. PMID 2882484 DOI: 10.1093/Nar/15.7.3192  0.556
1987 Hulsebos T, Coerwinkel-Driessen M, Wieringa B. RFLPs associated with pMC1, an anonymous single copy clone from the short arm of chromosome 19 [HGM8 assignment no. D19S14]. Nucleic Acids Research. 15: 378-378. PMID 2881255 DOI: 10.1093/Nar/15.1.378  0.352
1986 Hulsebos T, Westphal H, Peek R, Coerwinkel M, Wieringa B. pHW60, an anonymous single copy clone from the proximal portion of the long arm of chromosome 19 (HGM8 assignment no. D19S13). Nucleic Acids Research. 14: 7137-7137. PMID 2876412 DOI: 10.1093/Nar/14.17.7137  0.342
1981 Wieringa B, van der Zwaag-Gerritsen J, Mulder J, Ab G, Gruber M. Translation in vivo and in vitro of mRNAs coding for vitellogenin, serum albumin and very-low-density lipoprotein II from chicken liver. A difference in translational efficiency. European Journal of Biochemistry / Febs. 114: 635-41. PMID 7238505  0.414
1981 Wieringa B, Ab G, Gruber M. The nucleotide sequence of the very low density lipoprotein II mRNA from chicken. Nucleic Acids Research. 9: 489-501. PMID 7012793 DOI: 10.1093/Nar/9.3.489  0.496
1981 Meijlink FC, van het Schip AD, Arnberg AC, Wieringa B, Ab G, Gruber M. Structure of the chicken apo very low density lipoprotein II gene. The Journal of Biological Chemistry. 256: 9668-71. PMID 6270096  0.491
1979 Wieringa B, Roskam W, Arnberg A, van der Zwaag-Gerritsen J, Ab G, Gruber M. Purification of the mRNA for chicken very low density lipoproteinII and molecular cloning of its full-length double-stranded cDNA. Nucleic Acids Research. 7: 2147-63. PMID 230463 DOI: 10.1093/Nar/7.8.2147  0.539
1979 Willems M, Wieringa B, Mulder J, Ab G, Gruber M. Translation of vitellogenin mRNA in the presence of 7-methylguanosine 5'-triphosphate. Cap analogs compete with mRNAs on the basis of affinity for initiation-complex formation. European Journal of Biochemistry / Febs. 93: 469-79. PMID 217682 DOI: 10.1111/J.1432-1033.1979.Tb12845.X  0.407
1978 Wieringa B, Mulder J, van der Ende A, Bruggeman A, Ab G, Gruber M. Purification of vitellogenin mRNA and serum albumin mRNA from avian liver by preparative gel electrophoresis. European Journal of Biochemistry / Febs. 89: 67-79. PMID 699917  0.395
Show low-probability matches.